Takuro Miyazaki1, Matthew E J Callister2, Kevin Franks3, Padma Dinesh4, Takeshi Nagayasu5, Alessandro Brunelli4. 1. Department of Thoracic Surgery, St. James's University Hospital, Leeds, UK; Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Electronic address: miyataku@nagasaki-u.ac.jp. 2. Department of Respiratory Medicine, St. James's University Hospital, Leeds, UK. 3. Department of Clinical Oncology, St. James's University Hospital, Leeds, UK. 4. Department of Thoracic Surgery, St. James's University Hospital, Leeds, UK. 5. Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Abstract
OBJECTIVES: The aim of the study was to identify whether ventilation-to-carbon dioxide output (VE/V CO2) slope obtained from cardiopulmonary exercise test (CPET) as part of the preoperative functional workup was an independent prognostic factor for short and long-term survival after major lung resection. PATIENTS AND METHODS: 974 consecutive patients undergoing lobectomy (n = 887) or segmentectomy (n = 87) between April 2014 to March 2018 were included. 209 (22%) underwent CPET, and pulmonary function tests and several clinical factors including age, sex, performance status and comorbidities were retrospectively investigated to identify the prognostic factors with a multivariable Cox regression analysis. RESULTS: Among the patients with measured VE/V CO2, the incidence of cardiopulmonary complications in patients with high VE/V CO2 slope (>40) was 37% (19 of 51) vs. 27% (33 of 121) in those with lower slope values (p = 0.19). The 90-day mortality in patients with high VE/V CO2 slope (n = 8) was 16% vs. 5% (n = 6) in those with lower slope values (p = 0.03). No overall difference in 2-year mortality was identified between the two groups (VE/VCO2 > 40: 70% (54-80) vs. VE/VCO2 ≤ 40: 72% (63-80), log-rank test, p = 0.39). In a Cox regression analysis VE/VCO2 values were associated with poorer 2-year survival (HR 1.05, 95% CI 1.01-1.10, p = 0.030). CONCLUSIONS: We found that VE/V CO2 slope was an independent prognostic factor for the 90-day mortality and 2-year survival after anatomic pulmonary resection. This finding may assist during the multidisciplinary treatment decision-making process in high-risk patients with lung cancer.
OBJECTIVES: The aim of the study was to identify whether ventilation-to-carbon dioxide output (VE/V CO2) slope obtained from cardiopulmonary exercise test (CPET) as part of the preoperative functional workup was an independent prognostic factor for short and long-term survival after major lung resection. PATIENTS AND METHODS: 974 consecutive patients undergoing lobectomy (n = 887) or segmentectomy (n = 87) between April 2014 to March 2018 were included. 209 (22%) underwent CPET, and pulmonary function tests and several clinical factors including age, sex, performance status and comorbidities were retrospectively investigated to identify the prognostic factors with a multivariable Cox regression analysis. RESULTS: Among the patients with measured VE/V CO2, the incidence of cardiopulmonary complications in patients with high VE/V CO2 slope (>40) was 37% (19 of 51) vs. 27% (33 of 121) in those with lower slope values (p = 0.19). The 90-day mortality in patients with high VE/V CO2 slope (n = 8) was 16% vs. 5% (n = 6) in those with lower slope values (p = 0.03). No overall difference in 2-year mortality was identified between the two groups (VE/VCO2 > 40: 70% (54-80) vs. VE/VCO2 ≤ 40: 72% (63-80), log-rank test, p = 0.39). In a Cox regression analysis VE/VCO2 values were associated with poorer 2-year survival (HR 1.05, 95% CI 1.01-1.10, p = 0.030). CONCLUSIONS: We found that VE/V CO2 slope was an independent prognostic factor for the 90-day mortality and 2-year survival after anatomic pulmonary resection. This finding may assist during the multidisciplinary treatment decision-making process in high-risk patients with lung cancer.
Authors: Laurence Weinberg; Luka Cosic; Maleck Louis; Tom Garry; Patryck Lloyd-Donald; Stephen Barnett; Lachlan F Miles Journal: Ann Med Surg (Lond) Date: 2019-11-09
Authors: Andrej Mazur; Kristian Brat; Pavel Homolka; Zdenek Merta; Michal Svoboda; Monika Bratova; Vladimir Sramek; Lyle J Olson; Ivan Cundrle Journal: PLoS One Date: 2022-08-12 Impact factor: 3.752
Authors: Daniel Steffens; Hilmy Ismail; Linda Denehy; Paula R Beckenkamp; Michael Solomon; Cherry Koh; Jenna Bartyn; Neil Pillinger Journal: Ann Surg Oncol Date: 2021-06-08 Impact factor: 5.344